FDA revises final guidance on nitrosamine impurities
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)ComplianceGuidanceNitrosaminesPharmaceuticalsQuality Assurance and ControlUnited StatesRegulatory NewsJoanne S. EglovitchChemistry, Manufacturing and Controls (CMC)ComplianceGuidanceNitrosaminesPharmaceuticalsQuality Assurance and ControlUnited States